M Cugno Selected Research

M Cugno Research Topics

Disease

10	Chronic Urticaria 01/2020 - 02/2008
10	Inflammation (Inflammations) 11/2016 - 11/2000
7	Angioedema 02/2024 - 06/2001
5	Skin Diseases (Skin Disease) 10/2014 - 02/2009
4	Necrosis 06/2017 - 11/2000
4	Pyoderma Gangrenosum 06/2017 - 04/2011
3	Atypical Hemolytic Uremic Syndrome 02/2016 - 09/2014
3	Bullous Pemphigoid (Pemphigoid) 04/2015 - 02/2009
3	Blister (Bulla) 04/2015 - 02/2009
3	Sweet Syndrome (Acute Febrile Neutrophilic Dermatosis) 10/2014 - 10/2010
3	Systemic Scleroderma (Systemic Sclerosis) 04/2013 - 11/2000
3	Thrombosis (Thrombus) 01/2010 - 03/2000
2	Hypersensitivity (Allergy) 07/2017 - 12/2001
2	Anaphylaxis (Anaphylactic Shock) 07/2017 - 01/2007
2	Thrombotic Thrombocytopenic Purpura 02/2016 - 11/2015
2	Thrombotic Microangiopathies 02/2016 - 11/2015
2	Urticaria (Hives) 06/2014 - 01/2007
2	Asthma (Bronchial Asthma) 10/2011 - 01/2010
2	Eosinophilia 01/2010 - 02/2009
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 07/2006 - 09/2005
2	Liver Cirrhosis (Hepatic Cirrhosis) 12/2001 - 12/2001
1	Hemophilia B (Haemophilia B) 07/2017
1	Acne Vulgaris 06/2017
1	Hidradenitis Suppurativa 06/2017
1	Acquired Hyperostosis Syndrome (SAPHO Syndrome) 11/2016
1	Pyogenic arthritis, pyoderma gangrenosum, and acne 11/2016
1	Diarrhea 11/2015
1	Hemolytic-Uremic Syndrome 11/2015
1	Thrombocytopenia (Thrombopenia) 11/2015
1	Hemolytic Anemia 11/2015
1	Epidermolysis Bullosa Acquisita (Acquired Epidermolysis Bullosa) 01/2013
1	Hereditary Angioedemas 03/2012
1	type 2C Congenital disorder of glycosylation 12/2011
1	Hyperthermia 11/2011
1	Pain (Aches) 11/2011
1	Psoriasis (Pustulosis Palmaris et Plantaris) 07/2011
1	Wounds and Injuries (Trauma) 10/2010
1	Sepsis (Septicemia) 05/2010
1	Rheumatoid Arthritis 03/2010

Drug/Important Bio-Agent (IBA)

11	AutoantibodiesIBA 01/2020 - 02/2009
10	fibrin fragment D (D-dimer)IBA 01/2018 - 02/2008
7	BradykininIBA 02/2024 - 11/2000
6	CytokinesIBA 06/2017 - 11/2000
6	Prothrombin (Factor II)IBA 10/2011 - 02/2009
5	Immunoglobulin E (IgE)IBA 01/2020 - 12/2009
5	Thrombin FDA Link 03/2012 - 06/2001
5	Histamine (Histamine Dihydrochloride)FDA Link 01/2012 - 01/2007
4	AntibodiesIBA 07/2017 - 03/2000
4	ChemokinesIBA 11/2016 - 10/2010
4	Biomarkers (Surrogate Marker)IBA 06/2014 - 02/2009
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2011 - 11/2009
3	Immunoglobulin G (IgG)IBA 01/2020 - 03/2000
3	Complement System Proteins (Complement)IBA 02/2016 - 09/2014
3	C-Reactive ProteinIBA 10/2012 - 06/2010
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2011 - 04/2001
3	FibrinIBA 01/2010 - 03/2000
3	Tissue Plasminogen Activator (Alteplase)FDA Link 07/2006 - 03/2000
3	KininsIBA 12/2001 - 11/2000
2	AntigensIBA 07/2017 - 04/2015
2	InterleukinsIBA 06/2017 - 10/2010
2	thiamine triphosphorate (TTP)IBA 02/2016 - 11/2015
2	IgE Receptors (Fc epsilon RI)IBA 01/2016 - 12/2011
2	eculizumab FDA Link 03/2015 - 09/2014
2	Histamine Antagonists (Antihistamines)IBA 01/2012 - 12/2009
2	Proteins (Proteins, Gene)FDA Link 07/2011 - 02/2009
2	Matrix Metalloproteinases (MMPs)IBA 04/2011 - 10/2010
2	Peroxidase (Myeloperoxidase)IBA 04/2011 - 10/2010
2	Interleukin-8 (Interleukin 8)IBA 04/2011 - 10/2010
2	Interleukin-17 (Interleukin 17)IBA 04/2011 - 10/2010
2	Metalloproteases (Metalloproteinases)IBA 04/2011 - 10/2010
2	Thomsen-Friedenreich antibodiesIBA 07/2006 - 03/2000
1	Immunoglobulins (Immunoglobulin)IBA 01/2020
1	Omalizumab (Xolair)FDA Link 01/2018
1	Leukotriene C4IBA 07/2017
1	Factor IX (Coagulation Factor IX)FDA LinkGeneric 07/2017
1	Nonsense Codon (Nonsense Mutation)IBA 07/2017
1	Neutralizing AntibodiesIBA 07/2017
1	Interleukin-17 ReceptorsIBA 06/2017
1	PyrinIBA 11/2016
1	InflammasomesIBA 11/2016
1	Eosinophil Cationic ProteinIBA 04/2015
1	High-Molecular-Weight Kininogen (Kininogen, High Molecular Weight)IBA 12/2014
1	Fas Ligand Protein (Fas Ligand)IBA 10/2014
1	CD40 Ligand (CD40L)IBA 10/2014
1	Fibrin Fibrinogen Degradation ProductsIBA 06/2014
1	Collagen Type VIIIBA 01/2013
1	CCR3 ReceptorsIBA 10/2012
1	Fibrinolysin FDA Link 03/2012
1	2,5-dichloro-4-bromophenol (B 2)IBA 11/2011
1	EnzymesIBA 07/2011
1	ImmunosorbentsIBA 07/2011
1	Peptide Hydrolases (Proteases)FDA Link 10/2010
1	EndopeptidasesIBA 06/2010
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 06/2010
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2010
1	Infliximab (Remicade)FDA Link 03/2010
1	Monoclonal AntibodiesIBA 03/2010

Therapy/Procedure

2	Intradermal Injections 02/2011 - 12/2009
1	Extracorporeal Shockwave Therapy 04/2013
1	Therapeutics 03/2010